January 26, 2023
FIRE UP THE NEXT EXCUSE:
FDA has not observed stroke risk among seniors who received Pfizer booster after extensive review (Spencer Kimball, 1/26/23, CNBC)
"So far the data that we have seen suggests the absence of a safety risk for the bivalent boosters in age 65 years and older," Richard Forshee, deputy director of the FDA's biostatistics office, told the agency's independent vaccine committee.
Posted by Orrin Judd at January 26, 2023 1:02 PM